Studies | EBMT

Top

Study type

Disease

Group

Type of treatment

Text

OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION AS FIRST TRANSPLANT AFTER CHECKPOINT INHIBITORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN’S LYMPHOMA

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Carmen Martínez

EBMT - IDWP: Survey on Maribavir use in real life

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type of treatment

Principal investigator

Annalisa Paviglianiti

Impact of fludarabine dose modification in conditioning regimen for CAR T-cell therapy

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Acute Lymphatic Leukaemia (ALL)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Principal investigator

Guillaume Dachy

Survey on the organization and techniques of ATMP facilities by DARE-NL, EBMT, T2Evolve, and NXTGEN-HIGHTECH - a GoCART-coalition initiative

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type of treatment

Cellular therapies (other than DLI)

Principal investigator

Survey on ICU organization and ICU admission after haematopoietic cell transplantation with special emphasis on infectious causes

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Joanna Drozd-Sokolowska

Comparison of allogeneic hematopoietic stem cell transplantation (HCT) with CAR T-cells in relapsed and refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma (PMBCL)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Infections following CAR-T therapy. A retrospective collaborative study between the Infectious Diseases Working Party (IDWP), the Cellular Therapy and Immunobiology Working Party (CTIWP), the Transplant Complications Working Party (TCWP) of the EBMT, the European Hematology Association (EHA), and the Medical College of Wisconsin.

Closed Survey/Study

Non-Hodgkin’s Lymphoma (NHL)

Acute Lymphatic Leukaemia (ALL)

GoCART Coalition

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Patterns and treatments of relapse after commercial use of anti-CD19 CART therapy in patients with relapsed/refractory diffuse large B cell lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Type of treatment

Principal investigator

Alberto Mussetti

Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, CTIWP and TCWP

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Multiple Myeloma (MM) or other Plasma Cell Disorder (PCD)

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Autoimmune Diseases Working Party (ADWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Impact of Preceding Therapy of CART Cells in B-ALL and impact of consolidative HCT following complete remission post CART

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

GoCART Coalition

Type of treatment

Principal investigator

Valentín ORTIZ-MALDONADO

Practice patterns of holding and bridging therapy for mantle cell lymphoma patients in the CAR T-cell setting

Closed Survey/Study

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Gloria Iacoboni, MD, PhD, Pere Barba, MD, PhD

GvHD after donor-derived CAR-T cell infusion post allogeneic haematopoietic stem cell transplantation

Retrospective Studies

Complications: GvHD

Transplant Complications Working Party (TCWP)

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator